Manufacturer of Controlled Substances; Notice of Application, 57522 [E9-26744]
Download as PDF
<![CDATA[
57522
Federal Register / Vol. 74, No. 214 / Friday, November 6, 2009 / Notices
transmitted to the Secretary of
Commerce on or before November 23,
2009.)
5. Outstanding action jackets:
(1) Document No. GC–09–241:
Concerning Inv. No. 337–TA–640
(Certain Short-Wavelength Light
Emitting Diodes, Laser Diodes, and
Products Containing Same).
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: November 3, 2009.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. E9–26867 Filed 11–4–09; 11:15 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–09–033]
mstockstill on DSKH9S0YB1PROD with NOTICES6
Government in the Sunshine Act
Meeting Notice
AGENCY HOLDING THE MEETING: United
States International Trade Commission.
TIME AND DATE: November 19, 2009 at
9:30 a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED: 1. Agenda
for future meetings: None.
2. Minutes.
3. Ratification List.
4. Inv. No. 731–TA–1046 (Review)
(Tetrahydrofurfuryl Alcohol from
China)—briefing and vote. (The
Commission is currently scheduled to
transmit its determination and
Commissioners’ opinions to the
Secretary of Commerce on or before
November 30, 2009.)
5. Outstanding action jackets:
(1) Document No. GC–09–241:
Concerning Inv. No. 337–TA–640
(Certain Short-Wavelength Light
Emitting Diodes, Laser Diodes, and
Products Containing Same).
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
Issued: November 3, 2009.
By order of the Commission.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. E9–26869 Filed 11–4–09; 11:15 am]
BILLING CODE 7020–02–P
VerDate Nov<24>2008
18:23 Nov 05, 2009
Jkt 220001
INTERNATIONAL TRADE
COMMISSION
Drug
[USITC SE–09–032]
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
TIME AND DATE: November 17, 2009 at 11
a.m.
PLACE: Room 101, 500 E Street, SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED: 1. Agenda
for future meetings: None.
2. Minutes.
3. Ratification List.
4. Inv. Nos. 701–TA–459 and 731–
TA–1155 (Final) (Commodity
Matchbooks from India)—briefing and
vote. (The Commission is currently
scheduled to transmit its determinations
and Commissioners’ opinions to the
Secretary of Commerce on or before
November 30, 2009.)
5. Outstanding action jackets:
(1) Document No. GC–09–241:
Concerning Inv. No. 337–TA–640
(Certain Short-Wavelength Light
Emitting Diodes, Laser Diodes, and
Products Containing Same).
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
By order of the Commission.
Issued: November 3, 2009.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. E9–26868 Filed 11–4–09; 11:15 am]
BILLING CODE 7020–02–P
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 22,
2009, ISP Freetown Fine Chemicals, 238
South Main Street, Assonet,
Massachusetts 02702, made application
by renewal to the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Frm 00076
Fmt 4703
Sfmt 4703
I
II
II
II
II
The company plans to manufacture
bulk API, for distribution to its
customers. The bulk 2,5Dimethoxyamphetamine will be used
for conversion into non-controlled
substances.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than January 5, 2010.
Dated: October 30, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–26744 Filed 11–5–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Federal Bureau of Prisons
Notice of Availability of the Draft
Environmental Impact Statement for
the Criminal Alien Requirement 9
AGENCY: U.S. Department of Justice,
Federal Bureau of Prisons.
ACTION: Public comment on Draft
Environmental Impact Statement.
DEPARTMENT OF JUSTICE
PO 00000
2,5-Dimethoxyamphetamine
(7396).
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Schedule
SUMMARY: The U.S. Department of
Justice, Federal Bureau of Prisons
(Bureau) announces the availability of
the Draft Environmental Impact
Statement (DEIS) for the proposed
contract to secure additional inmate bed
space for the Bureau’s growing inmate
population.
As part of a recent initiative known as
the Criminal Alien Requirement 9 (CAR
9), the Bureau has identified a specific
requirement to confine a population of
up to 2,500 low-security adult male
inmates, that are primarily criminal
aliens. The Bureau is seeking to reduce
prison overcrowding by requesting
E:\FR\FM\06NON1.SGM
06NON1
]]>Agencies
[Federal Register Volume 74, Number 214 (Friday, November 6, 2009)]
[Notices]
[Page 57522]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26744]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on September 22, 2009, ISP
Freetown Fine Chemicals, 238 South Main Street, Assonet, Massachusetts
02702, made application by renewal to the Drug Enforcement
Administration (DEA) as a bulk manufacturer of the basic classes of
controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)............ I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
------------------------------------------------------------------------
The company plans to manufacture bulk API, for distribution to its
customers. The bulk 2,5-Dimethoxyamphetamine will be used for
conversion into non-controlled substances.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 5, 2010.
Dated: October 30, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-26744 Filed 11-5-09; 8:45 am]
BILLING CODE 4410-09-P
